US 11312964
Compositions and methods for modulating growth hormone receptor expression
granted A61KA61K47/549A61K47/56
Quick answer
US patent 11312964 (Compositions and methods for modulating growth hormone receptor expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K47/549, A61K47/56, A61P, A61P19/00